Hawkins, Inc. Files 8-K for Regulation FD Disclosure

TL;DR

Hawkins Inc. filed an 8-K today for a Reg FD disclosure. Details TBD.

AI Summary

Hawkins, Inc. filed an 8-K on August 8, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed as of August 8, 2025.

Why It Matters

This filing indicates Hawkins, Inc. is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.

Risk Assessment

Risk Level: low — This is a standard regulatory filing without immediate financial implications disclosed.

Key Players & Entities

• Hawkins, Inc. (company) — Registrant
• August 8, 2025 (date) — Date of Report
• Regulation FD (regulation) — Disclosure type

FAQ

Filing Documents

• hwkn-20250808.htm (8-K) — 32KB
• historicalfinancialinforma.htm (EX-99.1) — 305KB
• questionsandcommentsa.jpg (GRAPHIC) — 62KB
• 0000046250-25-000048.txt ( ) — 553KB
• hwkn-20250808.xsd (EX-101.SCH) — 2KB
• hwkn-20250808_lab.xml (EX-101.LAB) — 21KB
• hwkn-20250808_pre.xml (EX-101.PRE) — 12KB
• hwkn-20250808_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Hawkins, Inc. has prepared a presentation of historical financial information aligned to our current reporting segments for reference by investors, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01. The presentation will also be posted to our Investor Relations website at www.hawkinsinc.com/investors. As previously announced, we realigned our reporting segments to better reflect organizational changes made to our business and how we plan to manage our operations and allocate resources. We now operate and report using the following segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. There has not been any change in how the Water Treatment segment is managed. The Food and Health Sciences segment includes our nutrition, food, agriculture, and pharmaceutical businesses. The food, agriculture, and pharmaceutical businesses had previously been included within our historic Industrial reporting segment. We communicate material business and financial information to investors and other interested parties through our website at www.hawkinsinc.com (including our investor relations page at www.hawkinsinc.com/investors), press releases, and our filings with the U.S. Securities and Exchange Commission ("SEC"). Investors and other interested parties are hereby notified that we intend to use these media, including our website, to communicate with our shareholders and the public about our company. Information we make available through our website may be deemed to be material information. Accordingly, we encourage investors and other interested parties to review the information we make available on our website, in addition to information we announce through our press releases and filings with the SEC. Any updates to the list of disclosure channels through which we will announce information will be posted to our investor relations page on

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description Method of Filing 99.1 Hawkins, Inc. Historical Financial Information Aligned to New Reporting Segments Furnished Electronically 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HAWKINS, INC. Date: August 8, 2025 By: /s/ Jeffrey P. Oldenkamp Jeffrey P. Oldenkamp Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR